Project Details
Description
A multicenter, placebo-controlled field study evaluating gilvetmab in dogs with malignant melanoma
| Status | Active |
|---|---|
| Effective start/end date | 1/1/23 → 12/31/26 |
Funding
- MERCK
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.